The Treatment of Anxiety and Depression with Medicinal Cannabis

When: Wednesday, 10 May 2023

Time: 7 pm (AEST)

Cost: Free

The webinar has ended.

However, you can watch the recording in the Medihuanna Community.

Join Dr Kylie O'Brien and Dr Mihindu Jayasuriya in an exclusive webinar presented by Medihuanna and explore the Treatment of Anxiety and Depression with Medicinal Cannabis.

Dr Kylie O'Brien

Professor Kylie O’Brien PhD (Chin Med), MPH, B AppSc (Chin Med), BSc (Optom), Grad Cert Tert Ed

Adjunct Fellow NICM Health Research Institute; Adjunct Professor Torrens University

Kylie is Chief Scientific Officer of Cannim Group Pty Ltd and is considered an international expert on medicinal cannabis. Following a strong academic career in Chinese medicine, she entered the cannabis industry in 2018.

Kylie has been one of Australia’s leading educators in medicinal cannabis and has published two books to date: O’Brien & Blair, Medicinal Cannabis and CBD in Mental Healthcare (Cham: Springer, 2021) and O’Brien and Sali, A Clinician’s Guide to Integrative Oncology: What You Should Be Talking About with Cancer Patients and Why (Cham: Springer, 2017).

She is an experienced clinical researcher. In 2022, she led an observational study investigating the effectiveness and safety of medicinal cannabis in Australians. Kylie is a member of the TEQSA Expert Panel and a previous member of the TGA Advisory Committee for Complementary Medicines.

Dr Mihindu Jayasuriya

Dr. Mihindu Jayasuriya completed his Bachelor of Medicine and Bachelor of Surgery at Deakin University (2017). He subsequently worked at The Royal Melbourne Hospital for several years, rotating through various tertiary level subsurgical specialities including neurosurgery, cardiothoracic, and orthopaedic surgery, as well as spending a considerable time in intensive care medicine and anaesthetics.

He has since used his clinical experience and passion for cannabinoid medicine to transition to working at Releaf Clinics, where he is an Authorised Prescriber with the TGA for Medicinal Cannabis Products and holds the position of Chief Medical Officer (CMO) at Releaf Group Limited.

The Treatment of Anxiety and Depression with Medicinal Cannabis

Anxiety and depression are two leading reasons why people use medicinal cannabis. However, there can be confusion about what types of cannabis medicines are more appropriate. Is there sufficient evidence for the use of cannabis medicines and two of the major phytocannabinoids, CBD and THC in the treatment of these conditions?

In this presentation, Professor Kylie O’Brien and Dr. Mihindu Jayasuriya will discuss the current scientific evidence base around the use of medicinal cannabis for the treatment of anxiety and depression.

Two case studies will be presented, with an opportunity to discuss treatment strategies at the conclusion.

Claim CPD Hours

Medihuanna is a CPD approved education provider and you will be eligible to claim CPD hours by contacting your relevant CPD home. This webinar will include the following CPD allocation with reporting to your CPD home available:

Royal Australian College of General Practitioners' (RACGP) and Continuing Professional Development (CPD) Program

Educational Activity: 1 hour

© Medihuanna Pty Ltd, 2023. All rights reserved.